Casdin Private Growth Equity Fund II, L.P. - Insider Non-Derivative Transactions at STANDARD BIOTOOLS INC. (LAB) - (SEC)
Updated on December 12, 2024.
According to recent SEC insider information filed on Jan 5, 2024, Casdin Private Growth Equity Fund II, L.P.'s relationship to STANDARD BIOTOOLS INC. (LAB) is Director, and currently has 11,246,525 shares of Common Stock.
The chart below shows the number of shares owned, and the table shows the recent insider transactions.
You can see similar information for other LAB insiders.
Data Source: SEC.
Casdin Private Growth Equity Fund II, L.P. - Insider Non-Derivative Transactions of LAB Common Stock
Casdin Private Growth Equity Fund II, L.P. - Insider Non-Derivative Transactions at LAB
Items per page:
0 of 0
| Date | Transaction | No. of Shares | Price Per Share | Shares Owned After Transactions |
|---|---|---|---|---|
| Jan 6, 2024 | Acquisition -- (Common Stock) | 2744219 | 0 | 2744219 |
| Jan 6, 2024 | Acquisition -- (Common Stock) | 11246525 | 0 | 11246525 |
| May 20, 2023 | P -- (Common Stock) | 800000 | 2.29 | 1200000 |
| May 19, 2023 | P -- (Common Stock) | 150000 | 2.16 | 400000 |
| May 18, 2023 | P -- (Common Stock) | 250000 | 1.89 | 250000 |